Pol II transcribes protein-coding genes in eukaryotic cells and requires accessory factors to elongate the mRNA chain 1 . The essential elongation factor DRB-sensitivity-inducing factor (DSIF) 2 plays multiple roles during transcription 3, 4 and is partially conserved in bacteria and archaea 5, 6 . DSIF is globally required for normal RNA synthesis 7 , and it binds to the Pol II elongation complex (EC) after transcription initiation 8 , stimulates precursor-mRNA capping 9 , and enables promoter-proximal pausing of Pol II (ref. 10). In contrast to observations from the bacterial and archaeal systems 11, 12 , stable association of DSIF with Pol II ECs and the negative regulatory role of metazoan DSIF in elongation require an exiting RNA transcript [13] [14] [15] [16] . DSIF stabilizes a productive Pol II EC in vitro 14 and facilitates processive elongation 7 and termination at the 3′ ends of genes in vivo 17, 18 . DSIF comprises two subunits, SPT5 and SPT4. SPT5 contains a disordered N-terminal acidic region that is followed by an NGN (NusG N-terminal) domain 19 , several Kyrpides, Ouzounis, Woese (KOW) motifs 20 , and a mobile C-terminal-repeat region (CTR). The CTR is phosphorylated by the positive transcription elongation factor P-TEFb during the transcription cycle, and it coordinates transcription with RNA processing 3 . Previous studies have revealed that the NGN domain binds Spt4 (ref. 21) and is located above the active-center cleft of archaeal 22, 23 , yeast 23, 24 , and human 25 RNA polymerases. However, the exact locations of the Spt5 regions outside the NGN domain are unknown. Here we provide the structure of the complete Pol II-DSIF EC. The structure reveals the intricate domain architecture of DSIF, the locations of DSIF domains on the EC surface, and the contacts among DSIF, Pol II, and nucleic acids, and provides insights into how DSIF accomplishes its functional roles.
Pol II transcribes protein-coding genes in eukaryotic cells and requires accessory factors to elongate the mRNA chain 1 . The essential elongation factor DRB-sensitivity-inducing factor (DSIF) 2 plays multiple roles during transcription 3, 4 and is partially conserved in bacteria and archaea 5, 6 . DSIF is globally required for normal RNA synthesis 7 , and it binds to the Pol II elongation complex (EC) after transcription initiation 8 , stimulates precursor-mRNA capping 9 , and enables promoter-proximal pausing of Pol II (ref. 10) . In contrast to observations from the bacterial and archaeal systems 11, 12 , stable association of DSIF with Pol II ECs and the negative regulatory role of metazoan DSIF in elongation require an exiting RNA transcript [13] [14] [15] [16] . DSIF stabilizes a productive Pol II EC in vitro 14 and facilitates processive elongation 7 and termination at the 3′ ends of genes in vivo 17, 18 .
DSIF comprises two subunits, SPT5 and SPT4. SPT5 contains a disordered N-terminal acidic region that is followed by an NGN (NusG N-terminal) domain 19 , several Kyrpides, Ouzounis, Woese (KOW) motifs 20 , and a mobile C-terminal-repeat region (CTR). The CTR is phosphorylated by the positive transcription elongation factor P-TEFb during the transcription cycle, and it coordinates transcription with RNA processing 3 . Previous studies have revealed that the NGN domain binds Spt4 (ref. 21 ) and is located above the active-center cleft of archaeal 22, 23 , yeast 23, 24 , and human 25 RNA polymerases. However, the exact locations of the Spt5 regions outside the NGN domain are unknown. Here we provide the structure of the complete Pol II-DSIF EC. The structure reveals the intricate domain architecture of DSIF, the locations of DSIF domains on the EC surface, and the contacts among DSIF, Pol II, and nucleic acids, and provides insights into how DSIF accomplishes its functional roles.
RESULTS

Cryo-EM provides a model of the Pol II-DSIF EC
We prepared a mammalian Pol II EC on a synthetic DNA-RNA scaffold containing a 9-base-pair DNA-RNA hybrid, 11 DNA mismatches to mimic the transcription bubble, and a total of 50 nucleotides of RNA (Online Methods). We then added human DSIF and another elongation factor (NELF) and purified the resulting complex. Cryo-EM analysis revealed an intact Pol II-DSIF EC that lacked NELF, because NELF apparently dissociated during grid preparation, as is often observed with transient macromolecular complexes.
From a total of 2,549 cryo-EM micrographs, we obtained a reconstruction at a nominal resolution of 3.4 Å (Supplementary Figs. 1  and 2a,b) . In this reconstruction, high-quality density was observed for KOW5, but the remaining DSIF domains were visible only after the volume was filtered to 15-Å resolution ( Supplementary Fig. 2c ), thereby reflecting the mobility of the elongation factor on the Pol II surface. We therefore carried out focused 3D classification and obtained several particle classes that showed improved resolution for particular DSIF domains ( Supplementary Figs. 1 and 2d-h) .
These reconstructions enabled the building of a model for the Pol II-DSIF EC (Figs. 1 and 2a, Supplementary Fig. 3a , Table 1 and Supplementary Video 1). First, we placed our previous Pol II EC structure 25 into the density and extended it to include 20 nucleotides of RNA and the nontemplate single-stranded DNA in the bubble region. Second, the human NGN-SPT4 structure 26 was fitted into the density. Third, we generated models for the KOW1-linker1 (KOW1-L1) and KOW2-KOW3 (KOW2-3) domains on the basis of X-ray structures of the Saccharomyces cerevisiae homologs 27 and unambiguously placed these into the density. Finally, the density for the KOW5 domain revealed side chains and had overall high quality, thus allowing us to build an atomic model for this domain. These efforts yielded a partial model of the Pol II-DSIF EC.
Crystallography completes the Pol II-DSIF EC structure
Comparison of the cryo-EM density with the partial model of the Pol II-DSIF EC showed that one additional density remained in between the A r t i c l e s Pol II clamp, the stalk, and the placed KOW2-3 domain. This additional density corresponded to KOW4 and a preceding region in SPT5 and was used to guide the design of a protein construct for crystallization (SPT5 residues 536-646) (Online Methods). We solved the crystal structure for this SPT5 variant at ~1.6-Å resolution (Online Methods and Table 2 ).
The crystal structure revealed a tandem KOW domain comprising KOW4 and a preceding, previously undetected KOW motif that we named KOWx (Fig. 2b) . The KOWx-KOW4 (KOWx-4) crystal structure was placed into the single remaining cryo-EM density, thus completing the Pol II-DSIF EC model. The structure was finalized through flexible fitting and real-space refinement, as appropriate for the local resolution that we obtained (Online Methods). The final structure lacked only the N-and C-terminal mobile regions in SPT5 and the flexible KOW4-KOW5 linker region.
Overall architecture of the Pol II-DSIF EC
The final Pol II-DSIF EC structure (Fig. 1b) reveals five DSIF domains arrayed over the Pol II surface spanning from the DNA cleft to the RNA exit tunnel and explains previous cross-linking data 14, 24, 25 . DSIF forms multiple interactions with the Pol II clamp, protrusion, wall, stalk, and dock domains, and with both DNA and RNA. Through these interactions, DSIF recognizes the EC with RNA located in the RNA exit tunnel. We describe the location of these five DSIF domains on the EC surface, their interactions with Pol II and nucleic acids, and implications for their functions during transcription.
DSIF forms a DNA clamp
The Pol II-DSIF EC structure suggests that the NGN-SPT4 and KOW1-L1 domains together form a 'DNA clamp' . The NGN-SPT4 domain binds between the tips of the clamp and the protrusion of a closed active-center cleft (Fig. 3) . Compared with its archaeal counterpart, which has previously been shown to be positioned on the clamp 23 , the NGN-SPT4 domain is slightly rotated and shifted ( Supplementary  Fig. 4a) . A helix in the NGN domain (SPT5 residues 195-202) contacts the tip of the Pol II protrusion (Supplementary Fig. 4b ), and mutation of this helix in the S. cerevisiae homolog reduces DSIF activity 14 . The NGN domain also contacts the nontemplate DNA strand in the transcription bubble. This contact is consistent with reported cross-linking to DNA in this region 14 . Additionally, the SPT4 residue Arg11 protrudes toward upstream DNA.
The KOW1-L1 domain binds between the clamp and wall domains of Pol II. It contacts the zipper loop protruding from the clamp and positions the upstream DNA duplex. The KOW1-L1 domain surface contacting upstream DNA has been biochemically identified as a nucleic acid interaction site 27 . The position of upstream DNA is consistent with that observed in the free mammalian EC cryo-EM structure 25 but deviates from the path along the RPB2 wall that has been observed in a yeast EC crystal structure 28 . In the latter structure, the angle between the trajectories of the upstream and downstream DNA is approximately 30° wider. When restricted by KOW1-L1, upstream DNA orientations deviating by only ~5° were observed. SPT4   117  2  Dimerization   40   90°K   OW4-KOW5  linker   269 273  399  164  420  520 536  646  754  950  1087  979  703   KOWx-4  KOW6-7   KOW5   Acidic region  SPT5  NGN  KOW1-L1  KOW2-3 Nucleic acid contacts contribute to DSIF affinity for the EC In order to test the importance of the DNA and RNA clamps for the binding of DSIF to the Pol II EC, we mutated two DSIF regions that contact nucleic acids. To impair the DNA clamp, five residues of the NGN-domain helix α3 and loop α3-β4 that were in proximity to the nontemplate strand were mutated to alanine residues ( Supplementary Fig. 5a,b) . To impair the RNA clamp, we mutated four positively charged residues within the KOWx-KOW4 linker to either alanine or glutamate residues (Supplementary Fig. 5a,b) . Using an electrophoretic mobility shift assay, we then tested the ability of the wild-type and mutant DSIF proteins to bind a stabilized EC containing a 20-nucleotide RNA and a DNA-mismatch bubble. Both DSIF mutants displayed reduced affinity for the EC, in agreement with these regions contributing to the binding of DSIF to the EC (Supplementary Fig. 5c ). 
A r t i c l e s
A tandem KOW domain at the C-terminal end of SPT5
We did not observe cryo-EM density for SPT5 beyond the KOW5 domain, thus indicating that the CTR of SPT5 is mobile. However, bioinformatics analysis of the SPT5 sequence suggested the existence of an additional structured region in DSIF at the very C-terminal end of SPT5, following the CTR 19, 30 . We were indeed able to solve the crystal structure of this C-terminal region at 1.1-Å resolution (Online Methods and Table 2 ). The structure reveals another tandem KOW domain that we refer to as 'KOW6-7' (Supplementary  Fig. 3b ). This domain is apparently present only in metazoan and plant DSIF homologs and corresponds to a region in DSIF that has a role in the development of the fruit fly Drosophila melanogaster 31 and the zebrafish Danio rerio 32 . The sites of mutation leading to developmental defects are located within KOW6, and the mutations are predicted to destabilize the KOW6-7 structure. Both mutations have been associated with a defect in the negative regulatory roles of DSIF 31, 32 . Thus, this previously unannotated tandem KOW domain in SPT5 carries out an important function in vivo, and the molecular mechanisms involved remain to be discovered.
DISCUSSION
We used a combination of cryo-EM, X-ray crystallography, and molecular modeling to obtain the structure of the Pol II-DSIF EC. The results show that DSIF is a highly modular factor that adopts its structure upon binding to the Pol II EC containing a transcription bubble and the RNA transcript in the exit tunnel. DSIF contacts all EC-specific nucleic acid elements, including the nontemplate DNA in the transcription bubble, the upstream DNA, and the exiting RNA transcript. The structure thus suggests that DSIF maintains the EC with a DNA clamp and an RNA clamp. The DNA clamp formed by DSIF apparently contributes to the maintenance of a closed active-center cleft, because the NGN-SPT4 domain bridges both sides of the cleft and restricts the location of the nontemplate strand in the transcription bubble. Additionally, KOW1-L1 A r t i c l e s bridges the clamp and wall domains, closing over and helping to position upstream DNA. The DNA clamp is likely to be important for the maintenance of a processive EC, because clamp opening is predicted to weaken Pol II contacts with the DNA-RNA hybrid and is associated with polymerase pausing 33 . Disruption of the DNA clamp by mutation of the NGN domain abrogates the in vitro activity of DSIF in stabilizing the productive EC, and deletion of KOW1-L1 in yeast is lethal 14 . The function of the DNA clamp in maintaining the EC is also consistent with a role of the NGN domain in stabilizing a minimal transcription bubble in the bacterial system 34 . The RNA clamp formed by DSIF probably contributes to maintenance of the EC. The KOW4-KOW5 linker is part of the RNA clamp, and it contributes to the affinity of DSIF for the EC. Several arginine residues in this linker can be methylated, and inhibition of methylation increases DSIF association with Pol II (ref. 35) . Maintenance of the RNA in the exit channel is important for EC stability and processivity, because it prevents RNA from competing with the nontemplate DNA strand for the upstream template strand, a process that might lead to the formation of R loops in the wake of Pol II that destabilize the EC 36 . The RNA clamp may also restrain conformational changes in Pol II, because it bridges between the mobile polymerase modules 'core' and 'shelf ' 37 , which are known to move with respect to each other when multisubunit RNA polymerases adopt off-line states [38] [39] [40] .
The RNA clamp also has roles in polymerase pausing, because an SPT5 region encompassing KOW4 and KOW5 is required for promoter-proximal pausing of Pol II (ref. 29) . The KOW4-KOW5 linker can be phosphorylated by P-TEFb 41 , which is known to release Pol II from pause sites. These results suggest that the RNA clamp has positive and negative effects on transcription elongation and that these effects depend on post-translational modifications. A regulatory role of the RNA clamp, in contrast to a more general stabilizing function of the DNA clamp, is consistent with evolutionary considerations. Bacterial and archaeal DSIF homologs 5, 6 comprise the critical A r t i c l e s regions forming the DNA clamp but lack the regions forming the RNA clamp.
Our results further show that the observed DSIF binding to Pol II requires transcription initiation factors to have been released. Superposition of our Pol II-DSIF EC onto a structure of the human Pol II initiation complex 42 reveals many putative clashes of DSIF domains with initiation factors. The NGN-SPT4 domain would clash with the winged-helix domains in TFIIE and in the small TFIIF subunit. The KOW1-L1 domain would clash with the N-terminal TFIIB cyclin domain, and the KOW2-3 domain would clash with the TFIIEα subunit. A minor clash would occur between the KOWx-4 domain and the TFIIB zinc ribbon, which resides in the RNA exit tunnel. Competition between the archaeal homologs of DSIF and TFIIE for binding the polymerase has been described 43 .
Finally, the Pol II-DSIF EC structure also shows that the mobile CTR of SPT5 is positioned near exiting RNA. This location for the CTR is consistent with the function of the CTR in recruiting factors for 5′ RNA capping 44 and 3′ RNA processing 18 . RNA 3′ processing is coupled to transcription termination, when DNA is displaced from Pol II. Termination requires that the DNA and RNA clamps of DSIF be released. We speculate that when the transcribing Pol II-DSIF EC reaches the polyadenylation site at the end of a gene, the KOW5 domain remains bound to the EC to position 3′-processing factors, whereas the other DSIF domains are released from Pol II, thereby loosening the DNA and RNA clamps and rendering the polymerase prone to termination.
While our manuscript was under review, a description of the structure of a yeast (Komagataella pastoris) Pol II EC with bound DSIF was published 45 . Because the DSIF domains observed in our structure are all highly conserved in yeast, the two structures should be highly similar. Indeed, the published yeast structure shows the domains NGN-Spt4, KOW1-L1, and KOW5 in locations consistent with our human structure presented here. However, the yeast structure does not reveal the KOW2-3 domain, and the location of KOW4 differs from that observed in our structure. We note that we unambiguously placed both KOW2-3 and KOW4 in our cryo-EM density map. Generation of the complete model required a new X-ray crystallographic structure of the KOWx-4 domain that is conserved in yeast but was not available when the yeast Pol II-DSIF EC was reported 45 . The conserved Pol II-DSIF EC structures provide a foundation for a mechanistic investigation of eukaryotic transcription elongation and its regulation.
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ONLINE METHODS
Cloning and recombinant expression. Human DSIF and NELF variants were recombinantly expressed in Escherichia coli. Gene-optimized human SPT4 and SPT5 (Life Technologies) were cloned into a modified pETDuet-1 vector, in which the first cassette contained SPT4 with an N-terminal His 10 -Arg 8 -SUMO tag and a 3C protease site. DSIF variants were generated by PCR amplification of the full vector. In the NGN variant, R246, L247, Y249, W250, and N251 were mutated to alanine. In the KOWx-KOW4 linker variant, R577, K578, K579, and R582 were mutated to alanine (' A' mutant) or glutamate ('E' mutant). The SPT5 variants KOWx-4 (residues 536-646) and KOW6-7 (residues 979-1087) were cloned into the pOPINB vector containing an N-terminal His 6 tag and 3C protease site. Gene-optimized human NELF subunits 46 were cloned into a pETDuet-1 vector. NELF A (with an N-terminal His 6 tag and 3C protease site) and NELF C were cloned into the first open reading frame, and NELF B and NELF E were cloned into the second open reading frame. Internal ribosome entry sites were introduced between each pair of subunits.
Plasmids were transformed into E. coli BL21(DE3)RIL cells, and cells were grown at 37 °C in LB to an OD 600 of 0.5-0.6. Expression of full-length DSIF variants was induced by the addition of 1 mM IPTG and 10 µM ZnCl 2 for 3-4 h at 37 °C. Expression of NELF and truncated versions of SPT5 was induced by the addition of 1 mM IPTG for 3-4 h at 37 °C. To generate selenomethioninelabeled KOWx-4, we used feedback inhibition of methionine synthesis. A 10-mL LB starter culture of E. coli was used to inoculate a 1-L culture of methioninedepleted minimal medium (SelenoMet, Molecular Dimensions) supplemented with 40 mg/L L-methionine. Cells were harvested at an OD 600 of 1, washed twice with PBS, and used to inoculate 8 L of methionine-depleted minimal medium supplemented with 40 mg/L L-selenomethionine. The culture was grown at 37 °C for 3 h to an OD 600 of 0.6. The temperature was reduced to 20 °C, and medium was supplemented with 100 mg/L L-lysine, L-threonine, L-phenylalanine, and 50 mg/L L-leucine, L-isoleucine, and L-valine. The culture was grown for an additional 30 min before the induction of expression with 0.3 mM IPTG for 18 h. Cells were harvested by centrifugation and stored at −80 °C.
Protein preparation.
Unless otherwise stated, all steps were completed at 4 °C, and all buffers contained 1 mM DTT. Bovine Pol II was prepared from calf thymus (provided by E. Wolf, Gene Center, Ludwig Maximilians University of Munich, Germany) as previously described 25 , except that buffers included protease-inhibitor concentrations of 1 mM PMSF, 2 mM benzamidine, 0.6 µM leupeptin, and 2 µM pepstatin (1× protease inhibitor). E. coli pellets from the expression of full-length DSIF variants were lysed by sonication in buffer A (50 mM HEPES, pH 7.5 (25 °C), 500 mM NaCl, 10% (v/v) glycerol, and 10 µM ZnCl 2 ) supplemented with 150 mM imidazole and 1× protease inhibitor. Lysates were clarified by centrifugation and filtration through a 0.45-µm filter, and were applied to a 5-mL HisTrap HP column (GE Healthcare Life Sciences). Protein was eluted with buffer A containing 400 mM imidazole, then subjected to 3C protease cleavage during overnight dialysis into buffer B (50 mM HEPES, pH 7.5 (25 °C), 300 mM NaCl, 10% (v/v) glycerol, and 10 µM ZnCl 2 ) containing 130 mM imidazole. Cleaved DSIF was loaded a second time onto the HisTrap column to remove the cleaved tag and uncleaved complex. The eluate was applied to a Mono Q 5/50 GL anion-exchange column (GE Healthcare Life Sciences), which was washed with buffer C (50 mM HEPES, pH 7.5 (25 °C), 10% (v/v) glycerol, and 10 µM ZnCl 2 ) containing 350 mM NaCl. DSIF was eluted from the column in buffer C by using a linear gradient from 350 to 1,000 mM NaCl. A truncated form of SPT5 lacking the N-terminal region (N-terminal sequence MKKYAK, Edman sequencing) did not bind the Mono Q column. Residual nucleic acids and truncated SPT5 were removed by chromatography on a HiLoad 16/600 Superdex 200 pg column (GE Healthcare Life Sciences) equilibrated in buffer D (20 mM HEPES, pH 7.5 (25 °C), 500 mM NaCl, 10% (v/v) glycerol, and 10 µM ZnCl 2 ). Peak fractions were concentrated with a 50-kDa-cutoff Amicon spin concentrator (EMD Millipore) to a concentration of 4-5 mg/mL. The yield was approximately 0.8 mg per L of culture.
Cells expressing KOWx-4 were lysed by sonication in buffer E (50 mM HEPES, pH 7.5 (25 °C), 300 mM NaCl, and 10% (v/v) glycerol) supplemented with 50 mM imidazole and 1× protease inhibitor. Clarified lysate was applied to a 5-mL HisTrap HP column, which was washed with buffer E containing 100 mM imidazole and eluted with buffer E containing 250 mM imidazole. The eluate was subjected to 3C protease cleavage during overnight dialysis into buffer E supplemented with 45 mM imidazole. The cleaved product was passed over the HisTrap column, which was then washed with buffer E supplemented with 75 mM imidazole to remove uncleaved protein, cleaved tag, and 3C protease. The eluate was concentrated with a 3-kDa-cutoff Amicon spin concentrator and applied to a HiLoad 16/600 Superdex 75 pg column (GE Healthcare Life Sciences) equilibrated in buffer F (10 mM HEPES, pH 7.5, and 100 mM NaCl). Peak fractions were concentrated to ~35 mg/mL. Yields were approximately 10 mg and 1 mg per L of culture for native and selenomethionine-containing protein, respectively.
Cells expressing KOW6-7 were lysed as above in buffer E supplemented with 10 mM imidazole and 1× protease inhibitor. Clarified lysate was loaded onto a HisTrap column and eluted with buffer E containing 100 mM imidazole. The eluate was subjected to 3C protease cleavage overnight during dialysis into buffer G (50 mM HEPES, pH 7.5 (25 °C), 100 mM NaCl, and 10% (v/v) glycerol). The sample was then passed over a 5-mL HiTrap Q HP column (GE Healthcare Life Sciences) equilibrated in buffer G. The column flow-through material was adjusted to contain 300 mM NaCl and 10 mM imidazole. The sample was passed over the HisTrap column, concentrated with a 3-kDa-cutoff Amicon spin concentrator and applied, 10 mg at a time, to a Superdex 75 10/300 GL column (GE Healthcare Life Sciences) equilibrated in buffer F. Peak fractions were concentrated to 75 mg/mL with a 3-kDa-cutoff Amicon concentrator. The yield was approximately 40 mg per L culture.
E. coli pellets from the expression of NELF were suspended in buffer H (50 mM HEPES, pH 7.5 (25 °C), 300 mM NaCl, 10% (v/v) glycerol, 2.5 mM MgCl 2 , 0.1 mM CaCl 2 , and 30 mM imidazole) and lysed with a French press. Clarified lysate was loaded onto a HisTrap column, which was washed at room temperature with buffer E supplemented with 30 mM imidazole, 5 mM ATP, and 2 mg/mL denatured E. coli protein. The column was cooled to 4 °C and washed with several column volumes of buffer E containing 30 mM imidazole before complex elution with buffer E containing 300 mM imidazole. Complex-containing fractions were pooled and subjected to 3C protease cleavage during overnight dialysis into buffer E containing 22 mM imidazole. The sample was applied to the HisTrap column, and then the unbound sample was slowly diluted to 150 mM NaCl with buffer I (50 mM HEPES, pH 7.5 (25 °C), and 10% (v/v) glycerol). The sample was applied to a Mono Q 5/50 column and eluted with a linear gradient from 150 to 1,000 mM NaCl in buffer I, to remove excess NELF A. Complexcontaining fractions were combined and subjected to chromatography on a HiLoad 16/600 Superdex 200 column equilibrated in buffer J (50 mM HEPES, pH 7.5 (25 °C), 300 mM NaCl, and 10% (v/v) glycerol). Peak fractions were combined and concentrated to 5-6 mg/mL with a 50-kDa-cutoff Amicon concentrator. The yield was approximately 1 mg per L of culture.
Pol II-DSIF EC preparation. Pol II ECs were assembled by addition of a two-fold molar excess of preannealed template DNA (5′-GATCAAGCTCAAGTACTTAA GCCTGGTCTATACTAGTACTGCC-3′) and RNA (5′-UAACGAGAUCAUAA CAUUUGAACAAGAAUAUAUAUACAUAAAGACCAGGC-3′) to Pol II. The reaction was incubated on ice for 5 min and at 25 °C for 20 min. A four-fold molar excess of nontemplate DNA (5′-GGCAGTACTAGTATTCTAGTATTGAAAGTA CTTGAGCTTGATC-3′) was added, and the reaction was incubated for 20 min at 25 °C. DSIF was added in a two-fold molar excess over Pol II and incubated with ECs at 25 °C for 5 min. NELF was added in a 1.5-fold molar excess over Pol II and incubated at 25 °C for 20 min. The sample was applied to a Superdex 200 Increase 3.2/300 GL column (GE Healthcare Life Sciences) equilibrated in buffer K (5 mM HEPES, pH 7.25 (25 °C)), 150 mM NaCl, 10 µM ZnCl 2 , and 1 mM DTT). Peak fractions were collected and cross-linked for 20 min with 0.1% glutaraldehyde on ice in the dark. The reaction was quenched by addition of lysine, pH 7.8, to a concentration of 50 mM. After 25 min, the sample was applied to the Superdex 200 Increase 3.2/200 GL column, and peak fractions were used for cryo-EM.
Electron microscopy. Sample (4 µL) was applied to glow-discharged Quantifoil R 2/1 holey carbon grids, which were blotted and plunge frozen in liquid ethane with a Vitrobot Mark IV (FEI) operated at 4 °C and 100% humidity. Micrographs were collected with an FEI Titan Krios equipped with a Gatan K2 Summit detector, as previously described 25 . The TOM toolbox 47 was used to collect 2,549 movie images (nominal magnification of 37,000×) in 'super-resolution mode' (0.675Å per pixel), with a dose rate on the camera of ~6 electrons per pixel per second. One movie micrograph was collected per hole, with even illumination of the hole and a beam size of 2.3 µm. The total exposure time per movie was 9.9 s, with a total dose of 33 e − /Å 2 fractionated into 33 frames. The defocus range was from −0.6 µm to −3.6 µm. Movies were aligned and binned to the physical pixel size of 1.35 Å, as previously described 25 .
Image processing was performed in RELION 1.4 (ref. 48) . Initial contrast transfer function (CTF) parameters were estimated with CTFFIND4 (ref. 49 ). An initial data set of 12,749 particles (box size 256 pixels) was selected with semiautomated picking in EMAN2 (ref. 50) . Twelve classes were selected from unsupervised 2D classification of the initial data set and were used as references for RELION autopicking of all 2,549 micrographs, with a lower picking threshold applied to close-to-focus micrographs (0.6-1 µm). The autopicked particles were subjected to manual screening, thus resulting in a data set of 687,928 particles. 3D classification was carried out as outlined in Supplementary Figure 1 . Classification using a mask encompassing the Pol II EC separated out particles with a nearly invisible clamp domain and weak DNA density. Refinement of the remaining 662,347 particles resulted in a reconstruction in which the Pol II EC and DSIF KOW5 were visible at high resolution, and the remaining DSIF domains were visible after filtering to 15-Å resolution.
Owing to movement of nucleic acids and DSIF domains, 3D classification proved challenging. Consequently, we used a strategy of focused classifications within various regions of interest. One 3D classification used the first DSIF-EC reconstruction as a starting point and a mask encompassing DSIF KOW2-4. In order to further improve the density for the Pol II EC with KOW5, we subjected the data set to additional screening of micrographs according to CTF quality as well as to per-particle CTF fitting with a tilted plane geometry, as previously described 51 . Micrographs in which the CTF fit did not correlate well with the observed power spectrum until at least 0.8 of the Nyquist limit were removed, thus resulting in a data set of 659,282 particles ('DSIF-EC1'). All other 3D classifications were carried out with this data set as a starting point. Through the various focused classifications, different conformations of the DSIF domains, nucleic acids, Pol II stalk domain, and Pol II clamp domain were observed (Supplementary Fig. 1 ).
X-ray crystallography. Native KOWx-4 (36 mg/mL) and selenomethioninelabeled KOWx-4 (25 mg/mL) were subjected to crystallization directly after purification. A Crystal Gryphon LCP robot (ARI) was used to set sitting crystallization drops containing 100 nL protein solution plus 100 nL reservoir solution in 96-well INTELLI-PLATEs (ARI). Native X-ray diffraction data were obtained from a crystal grown with a reservoir solution of 0.1 M sodium cacodylate, pH 6.5, and 1.0 M trisodium citrate dihydrate. Transfer into cryoprotectant solution (0.1 M sodium cacodylate, pH 6.5, 1.0 M trisodium citrate dihydrate, and 27.5% (v/v) glycerol) was completed in four steps before flash freezing in liquid nitrogen. Selenomethionine diffraction data were obtained from an isomorphous crystal grown over a reservoir solution of 0.1 M bis-tris propane, pH 6.5, 0.2 M trisodium citrate dihydrate, and 18% (w/v) PEG 3350. Crystals were transferred to a cryoprotectant solution of 0.1 M bis-tris propane, pH 6.5, 0.2 M trisodium citrate dihydrate, 20% (w/v) PEG 3350, and 25% (v/v) glycerol in two steps, then flash frozen in liquid nitrogen. KOW6-7 was thawed directly before crystallization in EasyXtal 15-well Tool X-Seal plates (Qiagen). Drops contained 1 µL 75 mg/mL KOW6-7 and 1 µL reservoir solution over 600 µL of the same reservoir solution (0.1 M bis-tris propane, pH 7, and 3 M sodium formate). Crystals were transferred to cryoprotectant solution (0.1 M bis-tris propane, pH 7, 3 M sodium formate, and 10% (v/v) glycerol) in four steps.
KOWx-4 data and KOW6-7 native X-ray data were collected at the Swiss Light Source (Villigen, Switzerland) on beamline PX1 with an EIGER 16M detector (Dectris). KOW6-7 sulfur data were collected on beamline PXIII with a PILATUS 2M detector (Dectris). KOWx-4 and KOW6-7 native data were collected at wavelengths of 1.000031 Å and 0.999987 Å, respectively. Data were processed with XDS 52 , and space groups were confirmed with POINTLESS 53 . The KOWx-4 structure was phased by single-wavelength anomalous diffraction (SAD) by using the selenomethionine data collected at a wavelength of 0.971761 Å, whereas the KOW6-7 structure was phased by single wavelength anomalous dispersion of S atoms (S-SAD) by using the native protein crystal collected at a wavelength of 2.07505 Å. In both cases, an anomalous data set and a native data set (for phase extension) were used in conjunction with the SHELX C/D/E pipeline 54 . Models were built in COOT 55 and were subjected to iterative rebuilding and refinement in PHENIX 56 . Sodium ions were placed automatically by PHENIX. KOWx-4 was subjected to TLS refinement with ten groups. For KOW6-7, individual anisotropic B factors were refined, and stereochemistry and ADP weights were optimized. The final models displayed good stereochemistry with no Ramachandran outliers. For KOWx-4, 96.9% of residues fell within the preferred regions of the Ramachandran plot, whereas for KOW6-7, 97.7% fell within preferred regions.
Modeling of the Pol II-DSIF EC.
We first improved the Pol II EC model by adjusting it in COOT by using the DSIF-EC1 density. Upstream DNA was adjusted by using the map from class 3 of the upstream DNA mask focused classification, and additional nucleotides of exiting RNA were built by using the map from class 7 of the DSIF KOW2-4 mask focused classification ( Supplementary  Fig. 1 ). We then fitted the previously determined human KOW5 NMR structure (PDB 2E70), adjusted it in COOT, and refined it along with the rest of the Pol II EC model in real space in PHENIX. The RPB2 flap loop was modeled as stubbed amino acids by using the unsharpened DSIF-EC2 map, then was refined in real space using PHENIX. The crystal structure of human RPB4 and RPB7 (PDB 2C35) (ref. 57 ) was docked into the DSIF-EC2 map in UCSF Chimera 58 , and regions near the Pol II core were adjusted in COOT. Chain A of the KOWx-4 structure was fitted into the DSIF-EC2 map. Alternative side chain conformations were removed. The rotamer for SPT5 R577 was changed to a preferred rotamer consistent with the density. Additionally, SPT5 residues 627 and 616-622 were replaced with their counterparts from chain B of the crystal structure. A model for human KOW2-3 (SPT5 416-520) was generated in Modeller 59 with chain B of the yeast KOW2-3 structure (PDB 4YTL) (ref. 27 ) as a reference. KOW3 was fit into the DSIF-EC2 map (filtered to 4 Å and B-factor sharpened) and adjusted in COOT. The KOW3-KOWx linker was built into the DSIF-EC2 map. RPB4, RPB7, KOW3, and the KOW3-KOWx linker were refined into the DSIF-EC2 map (filtered to 4 Å and B-factor sharpened) in real space with PHENIX, with reference restraints based on the human RPB4-RPB7 crystal structure. KOW2 was flexibly fit into the DSIF-EC2 map (filtered to 5 Å, without B-factor sharpening) using the Relax protocol of Rosetta 60 .
A model for the human KOW1-L1 domain was generated using Modeller, with the yeast crystal structure of the homologous domain (PDB 4YTK) (ref.
27) used as a reference. The model was rigid-body fitted into the DSIF-EC3 map after removal of residues 319-334. The KOW1-L1 domain and upstream DNA were flexibly fitted into the DSIF-EC3 map in Rosetta. One prominent geometry outlier in the X-ray structure of the NGN domain (PDB 3H7H) (ref. 26 ) was corrected by converting a cis peptide bond at chain A residue 104 to a trans peptide bond, in agreement with the 1.6-Å electron density. This model was rigid-body fitted into the DSIF-EC3 density (filtered to 5 Å, without B-factor sharpening) in UCSF Chimera. Finally, the three missing amino acids connecting the NGN domain and KOW1 were modeled in COOT and were geometry regularized. To illustrate the path of the nontemplate DNA, phosphate atoms were placed in the center of the corresponding density (DSIF-EC5 map). Although substantial density for the stacked bases was observed, the position of the phosphate backbone was ambiguous, and as such we were unable to confidently model all atoms of the nontemplate DNA. Relative B factors were assigned to each residue of the model with PHENIX real-space ADP refinement into the DSIF-EC3 map.
The structure was validated with MolProbity 61 and EMRinger 62 , and by calculating the FSC of regions of the final model versus the corresponding map. EMRinger scores of 3.39 for the EC-KOW5 model and the DSIF EC1 map and 1.54 for the Pol II stalk plus KOW3-x model and DSIF-EC2 map (4 Å) supported correct peptide-backbone placement. Model-versus-map validation was carried out with the two maps for which side chain density was observed, DSIF-EC1 and DSIF-EC2. The Pol II core-DNA-RNA model was correlated against the DSIF-EC1 density, and the Pol II stalk plus KOW3 through KOWx were correlated against the DSIF-EC2 density. Masks for the correlation were generated with a map calculated from the model regions of interest, which was filtered to 15-Å resolution and extended with a soft edge. Local resolution was estimated as previously described 25 , except that an FSC cutoff of 0.2 and a voxel size of 30 were used. Local filtering was done as previously described 63 . Figures were generated with UCSF Chimera 58, 64 .
Electrophoretic mobility shift assay (EMSA). ECs were prepared by addition of preannealed template DNA and 5′-6-FAM-labeled RNA (DNA sequences as above; RNA sequence 5′-UAUAUGCAUAAAGACCAGGC-3′) to a 1.5-fold molar excess of concentrated Pol II, to ensure that most RNA was bound by Pol II. 
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